Singapore MedTech event highlights AI and robotics in real-world patient

A three-day medical technology showcase in Singapore demonstrated how artificial intelligence, robotics, and connected care systems are transitioning from research settings into practical patient applications. The event took place at Marina Bay Sands from September 9 to 11, attracting 13,854 attendees from 73 countries alongside 1,000 exhibitors representing 40 nations. Nearly 40% of participants came from abroad, indicating strong international engagement with MedTech advancements.

The gathering combined three components: Medical Fair Asia, Medical Manufacturing Asia, and the first-ever RehaCare Asia. Unlike traditional conferences focused on theoretical discussions, this event prioritized real-world applications, covering topics such as AI-assisted surgical planning, manufacturing challenges in MedTech, and the integration of rehabilitation robotics into clinical practice.

AI and connected health enter clinical practice

Singapore General Hospital showcased PEACH, an AI-powered chatbot capable of conducting pre-operative assessments for up to 120 patients daily. The system aligns with SGH’s established protocols, illustrating how AI can optimize routine procedures without compromising clinical standards. Meanwhile, Quanta Computer unveiled wearable and environmental sensors designed for continuous patient monitoring in both hospital and home environments, emphasizing the need for unified data systems across care settings.

Taiwanese companies presented AI tools for cardiovascular risk assessment, predicting antimicrobial resistance patterns, and automating hospital administrative tasks. Discussions also explored how to improve connectivity between hospitals, homes, and community care facilities while addressing the difficulties of validating and commercializing locally developed MedTech solutions.

The Innovation Partner Showcase zone brought emerging applications onto the exhibition floor, with Singapore-developed technologies from institutions including SUTD, the NUS Biorobotics Lab and Singapore Polytechnic, spanning wearable rehabilitation technologies, lightweight exoskeletons, AI-enabled healthy aging and AR/VR rehabilitation.

For Central Medical Services Co., Ltd. in Cambodia, the event provided exposure to technologies that could upgrade its healthcare infrastructure. CEO Sim Sovannara shared that “To strengthen healthcare in Cambodia, we must look beyond our borders, learn from other healthcare systems and build meaningful international partnerships. Medical Fair Asia gives us access to new technologies, modern equipment and practical solutions that can improve patient care while supporting the continued development of our healthcare institutions.”

Manufacturing barriers delay MedTech progress

At Medical Manufacturing Asia, implementation started further upstream: how to turn new technology into products that can be manufactured, commercialized and deployed safely at scale. At the Medical Manufacturing Forum, ASTAR SIMTech / AIMfg examined barriers preventing manufacturers from scaling AI, including fragmented data and complex manufacturing environments. ASTAR Innovation Factory was introduced, focused on the decisions required to take technologies from prototype to manufacturable product, including whether companies should build capabilities internally, outsource, partner or acquire. Its central message was straightforward: a great technology does not automatically make a great product.

Market Entry Briefings added another consideration for companies looking to expand across the region. Regulatory strategy, intended use, product classification and the licenses required to manufacture, import or distribute products can all affect how and when a technology reaches individual markets. Medical Manufacturing Asia also named Nelipak Healthcare Packaging Pte Ltd the winner of its 2026 Marketing Excellence Award, with Toki Automation Pte Ltd receiving the Special Recognition Award.

Mr. Steven Toy, Chairman, Singapore Precision Engineering and Technology Association (SPETA) shared, “Medical Manufacturing Asia reflects the strength of the partnership between SPETA and Messe Dusseldorf Asia, combining our industry knowledge and local manufacturing network with the exhibition’s international reach. This edition has provided Singapore companies with an important platform to demonstrate their precision-engineering and advanced-manufacturing capabilities, connect with the global MedTech community and explore new business opportunities. We look forward to continuing to develop MMA in line with the evolving needs of the industry.”

Rehabilitation technology must extend beyond hospitals

At the From Pilot to Practice: Closing Asia’s Rehabilitation Technology Adoption Gap forum, speakers stressed that clinical efficacy alone does not determine adoption. Patient goals, workflow fit, affordability, technical support, maintenance and whether technology can be used at home or in the community all matter.

Adjunct Associate Professor Dr Loh Yong Joo, Senior Consultant, Rehabilitation Medicine at Tan Tock Seng Hospital, highlighted the physical demands placed on therapists and the potential for robotics to reduce that burden while enabling patients to undertake more intensive rehabilitation. He shared: “Rehabilitation shouldn’t stop after discharge. It should continue in the community.”

The MotusAcademy RehaCare Asia Leadership Forum drew a full house. During the session, St Luke’s Hospital and Robotimize signed a memorandum of understanding to test, refine and integrate rehabilitation robotics into clinical practice.

The inaugural ASEAN Care Readiness Index 2026, commissioned by Messe Dusseldorf Asia and launched during the events, highlighted the challenge of translating healthcare ambition into practice. Among 300 healthcare and MedTech leaders surveyed across six Southeast Asian markets, 94% considered their organizations prepared for the next three to five years, yet 54% identified technology implementation capability as a barrier to future readiness.

Lars Wismer, Managing Director of Messe Dusseldorf Asia, shared: “The technology is advancing quickly, but implementation must keep pace. Over the three days, we have seen what that means in practice: technology must fit clinical workflows, support healthcare professionals, work beyond the hospital and be viable to manufacture and scale. These are no longer separate conversations. They determine whether innovation ultimately reaches patients.”